Health · 37 views
GLP-1 diabetes drugs linked to up to 68% higher hair loss risk
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 37 Community interest
Brief read Under 1 min brief 38 words
Summary
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Once-daily oral icotrokinra outperforms placebo in ulcerative colitisContinue reading
- Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancerContinue reading
- Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggestsContinue reading
- Melanoma vaccine reduces death or cancer recurrence by 42%Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow